Multiple Sclerosis Study
- We currently have a study for patients suffering from Relapsing Multiple Sclerosis. This trial is looking at how the study medication compares to an already FDA approved medication. Patients who qualify to participate in this study will be placed on a regimen of either the study medication or Aubagio® (teriflunomide) to treat their MS for up to two years. If you like the treatment, there is also an open label extension phase where you can receive the study medication for up to another 2.5 years. Click the button to view information about this study on clinicaltrials.gov. Learn More
At NEICR all of our clinical trials (and procedures associated with them) come at no cost to you. If you are interested in participating or have any questions, feel free to fill out the form below or give us a call at (203) 914-1903 for more information.
Use the form below to enroll